CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Roche Holding AG (Participation) - ROGz CFD

231.7
0.13%
Market Trading Hours* (UTC) Opens on Wednesday at 08:00

Mon - Fri: 08:00 - 16:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 1.0
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015658 %
Charges from full value of position ($-2.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015658%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006565 %
Charges from full value of position ($-1.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.006565%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Roche Holding AG ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 232
Open* 231.9
1-Year Change* -16.94%
Day's Range* 231.1 - 233.5
52 wk Range 230.90-297.75
Average Volume (10 days) 931.68K
Average Volume (3 months) 25.63M
Market Cap 201.07B
P/E Ratio 17.95
Shares Outstanding 798.65M
Revenue 60.77B
EPS 13.70
Dividend (Yield %) 3.86257
Beta 0.71
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 20, 2024 231.7 -0.2 -0.09% 231.9 233.6 230.9
Feb 19, 2024 232.0 2.9 1.27% 229.1 232.1 229.1
Feb 16, 2024 227.4 1.9 0.84% 225.5 228.7 225.1
Feb 15, 2024 225.6 0.8 0.36% 224.8 227.7 224.8
Feb 14, 2024 226.6 -1.1 -0.48% 227.7 228.0 226.1
Feb 13, 2024 228.0 -0.1 -0.04% 228.1 229.8 226.3
Feb 12, 2024 226.6 2.3 1.03% 224.3 227.0 223.6
Feb 9, 2024 224.4 -0.1 -0.04% 224.5 224.7 222.3
Feb 8, 2024 224.5 -2.7 -1.19% 227.2 229.6 223.7
Feb 7, 2024 227.7 -3.3 -1.43% 231.0 231.2 227.2
Feb 6, 2024 229.8 -0.8 -0.35% 230.6 231.2 226.6
Feb 5, 2024 229.8 -2.7 -1.16% 232.5 233.5 228.5
Feb 2, 2024 234.2 0.9 0.39% 233.3 235.9 232.7
Feb 1, 2024 232.6 -7.3 -3.04% 239.9 240.4 232.6
Jan 31, 2024 247.1 -1.1 -0.44% 248.2 248.2 244.7
Jan 30, 2024 246.5 1.8 0.74% 244.7 247.9 244.7
Jan 29, 2024 246.7 1.0 0.41% 245.7 247.1 245.3
Jan 26, 2024 246.0 3.7 1.53% 242.3 248.2 241.7
Jan 25, 2024 241.6 -2.0 -0.82% 243.6 243.9 239.6
Jan 24, 2024 244.2 0.9 0.37% 243.3 244.2 242.3

Roche Holding AG (Participation) Events

Time (UTC) Country Event
Thursday, February 22, 2024

Time (UTC)

17:00

Country

CH

Event

Roche Holding AG at Citi Virtual Oncology Leadership Summit
Roche Holding AG at Citi Virtual Oncology Leadership Summit

Forecast

-

Previous

-
Tuesday, February 27, 2024

Time (UTC)

08:00

Country

CH

Event

Roche Holding AG at UBS European Healthcare Conference (Virtual)
Roche Holding AG at UBS European Healthcare Conference (Virtual)

Forecast

-

Previous

-
Wednesday, March 6, 2024

Time (UTC)

15:00

Country

CH

Event

Roche Holding AG at TD Cowen Health Care Conference
Roche Holding AG at TD Cowen Health Care Conference

Forecast

-

Previous

-
Tuesday, March 12, 2024

Time (UTC)

10:59

Country

CH

Event

Roche Holding AG Annual Shareholders Meeting
Roche Holding AG Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, March 13, 2024

Time (UTC)

09:30

Country

CH

Event

Roche Holding AG Annual Shareholders Meeting
Roche Holding AG Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, March 21, 2024

Time (UTC)

08:00

Country

CH

Event

Roche Holding AG at Kepler Swiss Seminar
Roche Holding AG at Kepler Swiss Seminar

Forecast

-

Previous

-
Tuesday, March 26, 2024

Time (UTC)

08:00

Country

CH

Event

Roche Holding AG at Exane BNPP Healthcare Conference (Virtual)
Roche Holding AG at Exane BNPP Healthcare Conference (Virtual)

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 63281 62801 58323 61466 56846
Revenue 63281 62801 58323 61466 56846
Cost of Revenue, Total 18511 19348 15900 17377 16445
Gross Profit 44770 43453 42423 44089 40401
Total Operating Expense 45805 44646 39780 43918 42077
Selling/General/Admin. Expenses, Total 12124 12100 12075 13208 12453
Research & Development 14050 13707 12151 11690 11048
Depreciation / Amortization 378 351 446 268 183
Unusual Expense (Income) 2569 376 426 2677 3945
Other Operating Expenses, Total -1827 -1236 -1218 -1302 -1997
Operating Income 17476 18155 18543 17548 14769
Interest Income (Expense), Net Non-Operating -1040 -677 -463 -758 -419
Other, Net -109 -80 -115 -176 -202
Net Income Before Taxes 16327 17398 17965 16614 14148
Net Income After Taxes 13531 14935 15068 14108 10830
Minority Interest -1110 -1005 -773 -611 -365
Net Income Before Extra. Items 12421 13930 14295 13497 10465
Net Income 12421 13930 14295 13497 10500
Income Available to Common Excl. Extra. Items 12421 13930 14295 13497 10465
Income Available to Common Incl. Extra. Items 12421 13930 14295 13497 10500
Dilution Adjustment -1 -1 -1 -2 -1
Diluted Net Income 12420 13929 14294 13495 10499
Diluted Weighted Average Shares 808 860 865 864 860
Diluted EPS Excluding Extraordinary Items 15.3713 16.1965 16.5249 15.6192 12.1674
Dividends per Share - Common Stock Primary Issue 9.5 9.3 9.1 9 8.7
Diluted Normalized EPS 17.9847 16.5778 16.9515 18.2807 15.702
Total Extraordinary Items 35
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 29779 30986 32295 32088 30713
Revenue 29779 30986 32295 32088 30713
Cost of Revenue, Total 7619 8949 9562 10279 9069
Gross Profit 22160 22037 22733 21809 21644
Total Operating Expense 20015 25057 20748 24010 20636
Selling/General/Admin. Expenses, Total 6505 6479 5645 6544 5556
Research & Development 6449 7422 6628 7017 6690
Depreciation / Amortization 170 196 182 177 174
Unusual Expense (Income) 814 2584 -15 619 -243
Other Operating Expenses, Total -1542 -573 -1254 -626 -610
Operating Income 9764 5929 11547 8078 10077
Interest Income (Expense), Net Non-Operating -500 -568 -472 -524 -151
Other, Net -90 -19 -90 -43 -39
Net Income Before Taxes 9174 5342 10985 7511 9887
Net Income After Taxes 7563 4370 9161 6719 8216
Minority Interest -426 -479 -631 -592 -413
Net Income Before Extra. Items 7137 3891 8530 6127 7803
Net Income 7137 3891 8530 6127 7803
Income Available to Common Excl. Extra. Items 7137 3891 8530 6127 7803
Income Available to Common Incl. Extra. Items 7137 3891 8530 6127 7803
Dilution Adjustment 0 -1 0 -1 0
Diluted Net Income 7137 3890 8530 6126 7803
Diluted Weighted Average Shares 804 806 810 858 862
Diluted EPS Excluding Extraordinary Items 8.87687 4.8263 10.5309 7.13986 9.0522
Dividends per Share - Common Stock Primary Issue 0 9.5 0 9.3 0
Diluted Normalized EPS 9.73715 7.42355 10.5195 7.78732 8.8218
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 33816 35627 32942 31254 32244
Cash and Short Term Investments 9767 13031 12334 11858 13118
Cash 2841 5028 4536 4769 4139
Cash & Equivalents 2150 1822 1191 1306 2542
Short Term Investments 4776 6181 6607 5783 6437
Total Receivables, Net 13866 12651 11740 12150 11487
Accounts Receivable - Trade, Net 11527 10719 10056 10343 9687
Total Inventory 8605 7715 7194 6055 6621
Prepaid Expenses 1202 1869 1153 795 683
Other Current Assets, Total 376 361 521 396 335
Total Assets 88151 92317 86138 83091 78517
Property/Plant/Equipment, Total - Net 24208 24412 23270 23318 21818
Property/Plant/Equipment, Total - Gross 49408 48205 45664 45041 41822
Accumulated Depreciation, Total -25200 -23793 -22394 -21723 -20004
Goodwill, Net 10820 10809 9249 12456 8948
Intangibles, Net 9685 12117 12017 8358 9346
Long Term Investments 971 1069 1276 739 602
Note Receivable - Long Term 125 133 125 128 132
Other Long Term Assets, Total 8526 8150 7259 6838 5427
Total Current Liabilities 27239 38416 25401 24119 23033
Accounts Payable 3861 3844 3317 3176 2847
Accrued Expenses 12180 12497 11205 11214 10676
Notes Payable/Short Term Debt 2191 14618 2189 1694 722
Current Port. of LT Debt/Capital Leases 2071 833 2126 341 1971
Other Current Liabilities, Total 6936 6624 6564 7694 6817
Total Liabilities 60159 67828 49797 50344 50895
Total Long Term Debt 22282 17101 11096 13547 16077
Long Term Debt 21391 16076 10220 12668 16075
Capital Lease Obligations 891 1025 876 879 2
Deferred Income Tax 645 628 353 298 384
Minority Interest 4023 3856 3432 3120 2744
Other Liabilities, Total 5970 7827 9515 9260 8657
Total Equity 27992 24489 36341 32747 27622
Common Stock 107 160 160 160 160
Retained Earnings (Accumulated Deficit) 38937 34161 45571 40524 34935
Unrealized Gain (Loss) -59 -60 106 15 28
Other Equity, Total -10993 -9772 -9496 -7952 -7501
Total Liabilities & Shareholders’ Equity 88151 92317 86138 83091 78517
Total Common Shares Outstanding 799.181 800.403 853.126 855.756 854.428
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 30976 33816 30321 35627 31260
Cash and Short Term Investments 7509 9767 6808 13031 8017
Cash & Equivalents 3720 4991 4315 6850 5000
Short Term Investments 3789 4776 2493 6181 3017
Total Receivables, Net 11359 11919 11078 11126 11809
Accounts Receivable - Trade, Net 11089 11606 10809 10806 11656
Total Inventory 8496 8605 8292 7715 8319
Other Current Assets, Total 3612 3525 4143 3755 3115
Total Assets 84370 88151 86736 92317 87887
Property/Plant/Equipment, Total - Net 23895 24208 24324 24412 24300
Goodwill, Net 10564 10820 11160 10809 10623
Intangibles, Net 9129 9685 11735 12117 12510
Other Long Term Assets, Total 9806 9622 9196 9352 9194
Total Current Liabilities 26208 27239 27409 38416 25193
Payable/Accrued 4055 4556 3896 4637 4241
Notes Payable/Short Term Debt 2060 2191 2976 14618 2530
Current Port. of LT Debt/Capital Leases 2981 1769 2405 504 1196
Other Current Liabilities, Total 17112 18723 18132 18657 17226
Total Liabilities 57855 60159 61547 67828 50073
Total Long Term Debt 20345 21391 22369 16076 11285
Long Term Debt 20345 21391 22369 16076 11285
Deferred Income Tax 671 645 690 628 499
Minority Interest 3829 4023 3757 3856 3619
Other Liabilities, Total 6802 6861 7322 8852 9477
Total Equity 26515 27992 25189 24489 37814
Common Stock 107 107 107 160 160
Retained Earnings (Accumulated Deficit) 38333 38937 35740 34161 46686
Unrealized Gain (Loss) -72 -59 -151 -60 -90
Other Equity, Total -11853 -10993 -10507 -9772 -8942
Total Liabilities & Shareholders’ Equity 84370 88151 86736 92317 87887
Total Common Shares Outstanding 798.652 799.181 800.579 800.403 854.261
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 13531 14935 15068 14108 10865
Cash From Operating Activities 18415 20976 18566 22385 19979
Cash From Operating Activities 2906 2887 2808 2760 2292
Amortization 938 1556 1750 1532 1294
Non-Cash Items 9267 7718 6227 8883 10308
Cash Taxes Paid 4102 3343 3236 3543 3288
Cash Interest Paid 557 407 422 624 593
Changes in Working Capital -8227 -6120 -7287 -4898 -4780
Cash From Investing Activities -3536 -6552 -9067 -8634 -7195
Capital Expenditures -4797 -4652 -7858 -4896 -6746
Other Investing Cash Flow Items, Total 1261 -1900 -1209 -3738 -449
Cash From Financing Activities -16275 -13108 -9666 -14173 -10691
Financing Cash Flow Items -2340 -2333 -1992 -1716 -3316
Total Cash Dividends Paid -7832 -8132 -7964 -7682 -7253
Issuance (Retirement) of Debt, Net -6103 16348 290 -4775 -122
Foreign Exchange Effects -463 -193 -181 -184 -131
Net Change in Cash -1859 1123 -348 -606 1962
Issuance (Retirement) of Stock, Net 0 -18991
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 13531 9161 14935 8216
Cash From Operating Activities 18415 9509 20976 8212
Cash From Operating Activities 2906 1429 2887 1439
Amortization 938 471 1556 830
Non-Cash Items 9267 3799 7718 3323
Cash Taxes Paid 4102 2482 3343 2183
Cash Interest Paid 557 228 407 243
Changes in Working Capital -8227 -5351 -6120 -5596
Cash From Investing Activities -3536 1473 -6552 44
Capital Expenditures -4797 -2067 -4652 -2197
Other Investing Cash Flow Items, Total 1261 3540 -1900 2241
Cash From Financing Activities -16275 -13315 -13108 -9056
Financing Cash Flow Items -2340 -1374 -2333 -1211
Total Cash Dividends Paid -7832 -7672 -8132 -7955
Issuance (Retirement) of Debt, Net -6103 -4269 16348 110
Foreign Exchange Effects -463 -202 -193 73
Net Change in Cash -1859 -2535 1123 -727
Issuance (Retirement) of Stock, Net 0 -18991
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1844 22372151 50541 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.8532 20045265 2208289 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.847 12976127 39742 2023-09-30 LOW
UBS Asset Management (Switzerland) Investment Advisor 1.8359 12898101 25826 2023-09-30 LOW
Credit Suisse Funds AG Investment Advisor/Hedge Fund 1.6299 11450926 69518 2023-09-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 1.5735 11055080 62048 2023-09-30 LOW
Zürcher Kantonalbank (Asset Management) Bank and Trust 1.3184 9262276 -48615 2023-09-30 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.9311 6541705 303560 2023-09-30 LOW
Fidelity International Investment Advisor 0.8825 6199852 -14057 2023-09-30 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 0.6625 4654632 20709 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6344 4457325 1131 2023-09-30 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.6078 4269826 -124448 2023-06-30 LOW
Dodge & Cox Investment Advisor/Hedge Fund 0.5978 4200100 -5500 2023-09-30 LOW
California Public Employees' Retirement System Pension Fund 0.5839 4102151 -453583 2022-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.5124 3599675 -253068 2023-08-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.4875 3424807 0 2023-09-30 LOW
Flossbach von Storch AG Investment Advisor 0.4388 3082720 5931 2023-06-30 LOW
Capital Research Global Investors Investment Advisor 0.3727 2618264 416387 2023-09-30 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.3639 2556472 -580953 2023-09-30 LOW
Mawer Investment Management Ltd. Investment Advisor 0.3514 2468913 103 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Roche Company profile

About Roche Holding AG

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Roche Holding AG revenues increased 8% to SF62.8B. Net income decreased 3% to SF13.93B. Revenues reflect Diagnostics segment increase of 29% to SF17.76B, Chugai segment increase of 20% to SF4.51B, Rest of Europe segment increase of 16% to SF11.38B, Rest of Asia segment increase of 13% to SF9.75B, Germany segment increase of 29% to SF4.29B.

Equity composition

3 April 2001, 100 for 1 stock split.

Industry: Pharmaceuticals (NEC)

Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Oil - Crude

77.27 Price
-1.220% 1D Chg, %
Long position overnight fee 0.0081%
Short position overnight fee -0.0300%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

17,505.40 Price
-1.230% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

51,935.60 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,030.83 Price
+0.630% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading